Antimicrobial Potential of Betulinic Acid and Investigation of the Mechanism of Action against Nuclear and Metabolic Enzymes with Molecular Modeling

Natural products have important pharmacological activities. This study sought to investigate the activity of the compound betulinic acid (BA) against different strains of bacteria and fungi. The minimum inhibitory concentration (MIC) was determined and then the minimum bactericidal concentration (MBC) and minimum fungicidal concentration (MFC). After performing the in vitro tests, molecular modeling studies were carried out to investigate the mechanism of action of BA against the selected microorganisms. The results showed that BA inhibited the growth of microbial species. Among the 12 species (Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, Escherichia coli, Mycobacterium tuberculosis, Candida albicans, C. tropicalis, C. glabrata, Aspergillus flavus, Penicillium citrinum, Trichophyton rubrum, and Microsporum canis) investigated, 9 (75%) inhibited growth at a concentration of 561 µM and 1 at a concentration of 100 µM. In general, the MBC and MFC of the products were between 561 and 1122 μM. In silico studies showed that BA presented a mechanism of action against DNA gyrase and beta-lactamase targets for most of the bacteria investigated, while for fungi the mechanism of action was against sterol 14α-demethylase (CYP51) targets and dihydrofolate reductase (DHFR). We suggest that BA has antimicrobial activity against several species.

[1]  D. Stan,et al.  Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation , 2021, Frontiers in Pharmacology.

[2]  M. Scotti,et al.  A new labdane diterpene from the aerial segments of Leptohyptis macrostachys (L'Hérit.) Harley & J.F.B. Pastore , 2021 .

[3]  V. Rodrigues-Junior,et al.  Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis. , 2021, Tuberculosis.

[4]  Joo Hee Kim,et al.  Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway , 2021, PloS one.

[5]  R. Forgione,et al.  Understanding the Antibacterial Resistance: Computational Explorations in Bacterial Membranes , 2021, ACS omega.

[6]  Birbal Singh,et al.  Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review , 2021, Frontiers in Microbiology.

[7]  David S. Goodsell,et al.  RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences , 2020, Nucleic Acids Res..

[8]  Paolo Guglielmi,et al.  Natural compounds and extracts as novel antimicrobial agents , 2020, Expert opinion on therapeutic patents.

[9]  C. Nonaka,et al.  Betulinic Acid Exerts Cytoprotective Activity on Zika Virus-Infected Neural Progenitor Cells , 2020, Frontiers in Cellular and Infection Microbiology.

[10]  P. Chung.  Novel targets of pentacyclic triterpenoids in Staphylococcus aureus: A systematic review. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[11]  M. Scotti,et al.  Lignans and Neolignans anti-tuberculosis identified by QSAR and Molecular Modeling. , 2020, Combinatorial chemistry & high throughput screening.

[12]  S. Bak,et al.  Evolution of Structural Diversity of Triterpenoids , 2019, Front. Plant Sci..

[13]  P. Le Pape,et al.  A Decade of Antifungal Leads from Natural Products: 2010–2019 , 2019, Pharmaceuticals.

[14]  P. Le Pape,et al.  A Decade of Antifungal Leads from Natural Products: 2010–2019 , 2019, Pharmaceuticals.

[15]  Milad Iranshahy,et al.  Review on plant antimicrobials: a mechanistic viewpoint , 2019, Antimicrobial Resistance & Infection Control.

[16]  V. Lamour,et al.  Cryo-EM structure of the complete E. coli DNA gyrase nucleoprotein complex , 2019, Nature Communications.

[17]  R. Ibrahim,et al.  Antibacterial activities of triterpenoidal compounds isolated from Calothamnus quadrifidus leaves , 2019, BMC Complementary and Alternative Medicine.

[18]  G. Guilhon,et al.  Betulinic Acid Prevents the Acquisition of Ciprofloxacin-Mediated Mutagenesis in Staphylococcus aureus , 2019, Molecules.

[19]  S. Gnoatto,et al.  Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs , 2019, Biomolecules.

[20]  Angelika Sysak,et al.  Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines , 2018, In Vivo.

[21]  Osmar Norberto de Souza,et al.  Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis , 2018, PloS one.

[22]  J. Quetin-Leclercq,et al.  Natural and hemi-synthetic pentacyclic triterpenes as antimicrobials and resistance modifying agents against Staphylococcus aureus: a review , 2018, Phytochemistry Reviews.

[23]  R. Stavenger,et al.  A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance , 2018, Nucleic acids research.

[24]  R. Humphries,et al.  CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests , 2018, Journal of Clinical Microbiology.

[25]  Fabian Sievers,et al.  Clustal Omega for making accurate alignments of many protein sequences , 2018, Protein science : a publication of the Protein Society.

[26]  J. York,et al.  Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis , 2017, The Journal of Biological Chemistry.

[27]  A. Fusco-Almeida,et al.  Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis , 2017, Front. Microbiol..

[28]  L. Silver.  Appropriate Targets for Antibacterial Drugs. , 2016, Cold Spring Harbor perspectives in medicine.

[29]  P. Nordmann,et al.  Crystal Structure of the Pseudomonas aeruginosa BEL-1 Extended-Spectrum β-Lactamase and Its Complexes with Moxalactam and Imipenem , 2016, Antimicrobial Agents and Chemotherapy.

[30]  S. Park,et al.  Recent studies on betulinic acid and its biological and pharmacological activity , 2015, EXCLI journal.

[31]  F. O. Pereira,et al.  Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis , 2015, Pharmaceutical biology.

[32]  R. Ribeiro‐dos‐Santos,et al.  Potent anti-inflammatory activity of betulinic acid treatment in a model of lethal endotoxemia. , 2014, International immunopharmacology.

[33]  S. Alakurtti,et al.  Screening and Characterisation of Antimicrobial Properties of Semisynthetic Betulin Derivatives , 2014, PloS one.

[34]  A. Fuentefria,et al.  Synthesis of Isosteric Triterpenoid Derivatives and Antifungal Activity , 2014, Chemical biology & drug design.

[35]  G. Baker,et al.  Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors , 2012, Journal of enzyme inhibition and medicinal chemistry.

[36]  F. Abas,et al.  Inhibition of Growth of Highly Resistant Bacterial and Fungal Pathogens by a Natural Product , 2011, The open microbiology journal.

[37]  D. McPhee,et al.  Molecules Best Paper Award 2013 , 2013, Molecules.

[38]  M. Soares,et al.  Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice , 2009, Parasitology Research.

[39]  John D. Westbrook,et al.  The Protein Model Portal , 2008, Journal of Structural and Functional Genomics.

[40]  A. Okoh,et al.  Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends , 2008 .

[41]  Â. R. Antoniolli,et al.  Atividade antimicrobiana dos óleos essenciais: uma abordagem multifatorial dos métodos , 2007 .

[42]  René Thomsen,et al.  MolDock: a new technique for high-accuracy molecular docking. , 2006, Journal of medicinal chemistry.

[43]  Perumal Yogeeswari,et al.  Betulinic acid and its derivatives: a review on their biological properties. , 2005, Current medicinal chemistry.

[44]  L. Sabath,et al.  Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  H. Greger,et al.  Testing of antifungal natural products: methodologies, comparability of results and assay choice , 2000 .

[46]  B. Anderson,et al.  The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. , 1995, Structure.

[47]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[48]  P M Gaylarde,et al.  Lectins , 1985 .

[49]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[50]  B. Matthews.  Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[51]  Gabriela Bitencourt-Ferreira,et al.  Molegro Virtual Docker for Docking. , 2019, Methods in molecular biology.

[52]  Isabelle Cristine de Melo Freire,et al.  Atividade antibacteriana de Óleos Essenciais sobre Streptococcus mutans e Staphylococcus aureus , 2014 .

[53]  Clinical,et al.  Performance standard for antimicrobial susceptibility testing. , 2010 .

[54]  Manuela Pavan,et al.  DRAGON SOFTWARE: AN EASY APPROACH TO MOLECULAR DESCRIPTOR CALCULATIONS , 2006 .

[55]  K. Tanzawa,et al.  BIOLOGICAL ACTIVITIES , 2006 .

[56]  C. Aiken,et al.  Betulinic acid derivatives as HIV-1 antivirals. , 2005, Trends in molecular medicine.

[57]  D. Eisenberg,et al.  VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.

[58]  J. M. Filho,et al.  Constituents of the stem-bark of Zizyphus joazeiro , 1985 .

[59]  E. Abraham.  Chapter XI - The Antibiotics , 1963 .